Authors' objectives:
               Respiratory syncytial virus (RSV) is a virus that infects the lungs and upper airways. This virus spreads every winter, with the RSV season in Ireland typically running from October to March. In healthy individuals, infection with RSV can usually be managed without needing to see a doctor. However, RSV can cause more severe infections in some people which may lead to them being hospitalised. Groups vulnerable to serious complications include infants, young children and older adults.

At the request of the Department of Health, the Health Information and Quality Authority (HIQA) agreed to undertake a rapid health technology assessment (HTA) of alternative infant and adult immunisation strategies against RSV in Ireland.